Jaguar Animal Health, Inc. (JAGX) vs Moolec Science SA (MLEC)

Jaguar Animal Health, Inc. and Moolec Science SA are both Biotechnology companies. Jaguar Animal Health, Inc. is the larger, with a market value of $950.0K against $620.0K — 1.5× the size. Moolec Science SA has the higher net margin (−105.7% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 17 metrics below, Moolec Science SA leads on 10 and Jaguar Animal Health, Inc. on 7.

Valuation

Metric JAGX MLEC Biotechnology median
P/E n/m n/m 10.60
P/S 0.00 0.03 9.40
P/B 0.00 0.01 2.13
Price to free cash flow n/m 0.01 25.18
EV/EBITDA 0.14 1.76 0.66
EV/Sales (0.12) 8.37 9.02
Earnings yield (1,425,993.60%) (3,822.12%) (32.88%)
Free cash flow yield (34,129.63%) 8,301.70% (23.13%)

Profitability

Metric JAGX MLEC Biotechnology median
Gross margin 82.31% 2,373.25% 68.51%
Operating margin (93.10%) 244.93% 0.00%
Net margin (188.46%) (105.71%) 0.00%
Free cash flow margin (24.03%) 0.00% 0.00%
Return on equity (1,125.38%) 0.00% (51.96%)
Return on assets (127.14%) 0.00% (46.06%)
Return on invested capital (28,393.64%) 0.00% 0.00%

Growth

Metric JAGX MLEC Biotechnology median
Revenue growth (TTM) 135.52% — 6.76%
EPS growth (last fiscal year) 82.42% (793.17%) 29.88%
Revenue growth, 5-year CAGR 4.17% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JAGX MLEC Biotechnology median
Debt to equity 0.35 4.37 0.00
Current ratio 0.69 0.15 4.97
Net debt to EBITDA (0.17) (2.73) 1.01

Dividend

Metric JAGX MLEC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric JAGX MLEC Biotechnology median
Market cap 950.00k 620.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack